cbdMD Inc.
YCBD | AMEX
$0.50
-$0.02 (-3.86%)
At close: Aug 27, 2026, 3:59 PM ET
Company Profile
cbdMD, Inc. is engaged in the production and distribution of a diverse array of cannabidiol (CBD) products. The company oversees and markets several consumer-oriented, hemp-derived CBD brands, notably its primary brand cbdMD, alongside Paw CBD and cbdMD Botanicals. Under the cbdMD label, its offerings span various items, including CBD tinctures, edible gummies, topical applications, capsules, bath bombs, bath salts, and solutions designed to aid sleep. Furthermore, its Paw CBD brand caters to pets with veterinarian-formulated products such as tinctures, edible chews, and topical treatments. The company's merchandise reaches customers throughout the United States via its proprietary e-commerce platform, various third-party online retail sites, wholesale partners, and physical brick-and-mortar establishments. cbdMD, Inc. also maintains a research collaboration with the University of Mississippi, focusing on the discovery of novel cannabinoids. Incorporated in 2015, the firm was previously known as Level Brands, Inc. before officially changing its name to cbdMD, Inc. in May 2019, and its corporate headquarters are situated in Charlotte, North Carolina.
Key Executives
| Name | Position |
|---|---|
| T. Ronan Kennedy | Chief Executive Officer, Chief Financial Officer, Principal Executive Officer & Director |
| Shannon Charles | Chief Marketing Officer |
| Wade Brown | Chief Marketing Officer |
| Zeb Booker | Chief Technology Officer |
| Bradley Whitford | Chief Accounting Officer, Treasurer & Secretary |
| David Johnson | Senior Vice President of Business Development |
| Francisco Mangual | Senior Vice President of Sales |
| Lance Blundell | General Counsel |
| Sibyl Swift | CSO, Vice President of Regulatory Affairs & Director |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| May 20, 2026 | 8-K | Current Report |
| May 14, 2026 | 10-Q | Quarterly Report |
| Apr 16, 2026 | 4 | Filing |
| Apr 16, 2026 | 4 | Filing |
| Apr 16, 2026 | 4 | Filing |
| Apr 16, 2026 | 4 | Filing |
| Apr 16, 2026 | 4 | Filing |
| Apr 16, 2026 | 4 | Filing |
| Apr 15, 2026 | 8-K | Current Report |
| Apr 01, 2026 | 8-K | Current Report |
cbdMD Inc.
| Country | United States |
| IPO Date | Nov 17, 2017 |
| Industry | Drug Manufacturers - Specialty & Generic |
| Sector | Healthcare |
| Employees | 42 |
| CEO | T. Ronan Kennedy |
Contact Details
2101 Westinghouse Blvd Charlotte,
North Carolina 28217 United States
Stock Details
| Ticker Symbol | YCBD |
| Exchange | AMEX |
| Fiscal Year | October - September |
| Reporting Currency | USD |
| CIK Code | 0001644903 |
| CUSIP Number | 12482W408 |
| ISIN Number | US12482W4087 |
| SIC Code | 2844 |
Add to Watchlist
Select watchlists to add or remove YCBD